Delivery Order SPE2DB20D1109-SPE2DB22FQ17H

Award Date 9/23/22
Potential Completion Date 9/26/22
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Latuda 20 mg tablets. The $20,964.90 firm-fixed price contract has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Latuda 120 mg tablets. The contract has a ceiling value of $2,548.62 and a period of performance through August 25, 2023. It is a firm-fixed-price delivery order contract, with no set-aside requirements indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Latuda 80 mg tablets. The contract has a ceiling value of $1,529.32 and a period of performance through July 18, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the prescription drug Latuda (40 mg tablets) with a ceiling value of $1,168.26 and a period of performance through August 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,572.93 firm-fixed-price contract is for the delivery of Latuda 80 mg tablets, a specialty medication used to treat mental health conditions. The contract has an ultimate completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The award is for the supply of the pharmaceutical product Latuda 20 mg tablets, with a ceiling value of $17,222.07 and a period of performance through September 15, 2022. The contract is a firm fixed-price, delivery order type, with no set-aside designation indicated....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 80 mg Latuda tablets. The contract, valued at $4,127.25, has a firm fixed price and is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to military treatment programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Latuda 60 mg tablets. The contract has a ceiling value of $2,220.04 and a period of performance through July 29, 2022. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,345.33, is for the supply of LATUDA 20 MG TABLET 30S, a specialty medication. The award has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Latuda 20 mg tablets in a 30-count package, with a total ceiling value of $1,846.96 and an ultimate completion date of December 31, 2024. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FQ17H
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Latuda 20 mg tablets. The $11,808.00 firm fixed price contract has a completion date of September 26, 2022 and was awarded on September 23, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities.

Generated 2/27/25, 11:45 AM